Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2005
11/09/2005EP1592662A1 Process for the preparation of fexofenadine
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1240139B1 Method for producing n-alkenyl amides
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1179341B1 Remedies or preventives for diseases in association with chemokines
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694702A Neurotrophic factor production promoter
11/09/2005CN1693304A Process for preparing HIV protease inhibitor neffinarve
11/08/2005US6962998 Resolution in presence of reducing catalyst
11/08/2005US6962997 Process and intermediates for resolving piperidyl acetamide steroisomers
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/03/2005WO2005103042A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005WO2005103001A1 Phenyl acetamides
11/03/2005WO2005103000A1 N-`4-4(4-morpholinyl) phenyl!-`(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
11/03/2005WO2005102999A2 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005102335A2 Methods of treating sleep disorders
11/03/2005WO2005011611A3 Bicyclic compounds and compositions as pdf inhibitors
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245745 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245743 depression and/or anxiety, obesity, urinary disorder; 5-(2-Methoxyphenyl)-N-[3-(4-Piperidinyl)Phenyl]Pentanamide
11/03/2005US20050245574 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
11/03/2005US20050245573 N-substituted benzene sulfonamides
11/03/2005US20050245572 Naphthyl ether compounds and their use
11/03/2005US20050245566 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005DE102004051539A1 Novel pyridinedione derivatives are used as light stabilizers for organic materials, e.g. plastics, lacquers, photographic products or pharmaceuticals
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563756A1 Phenyl acetamides
11/03/2005CA2563330A1 A process for the preparation of 2,2-disubstituted pyrroles
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005CA2560882A1 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1513813B1 Opioid receptor antagonists
11/02/2005EP1392679B1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
11/02/2005EP1233989B1 Inhibition of polymerization of unsaturated monomers
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1140842B1 Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/02/2005CN1689405A Compounds, compositions, and methods for controlling biofilms
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100311A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005WO2005100310A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005061483A3 Modulators of peripheral 5-ht receptors
10/27/2005WO2005058826A8 New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin
10/27/2005WO2005058824A3 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b
10/27/2005WO2004089903A9 Piperidine derivatives as renin inhibitors for the treatment of hypertension
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050240022 Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine)
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239847 Novel crude and crystalline forms of lercanidipine hydrochloride
10/27/2005US20050239838 Novel antihistamines; modulating sleep by a doxepin analog; circadian rhythm abnormality, jet lag, shift-work disorders, delayed sleep phase syndrome, advanced sleep phase syndrome and non-24 hour sleep-wake disorder
10/27/2005US20050239837 Cyclization of 2-(3,4-dimethoxybenzyl0-3-(N-benzyl-4-piperidine)propionic acid; salt formation using hydrigen chloride
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239834 Novel 4-diphenylmethyl piperidine derivatives
10/27/2005US20050239831 Bupivacaines
10/27/2005US20050239829 Novel piperidine compound
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239827 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239801 Novel compounds
10/27/2005US20050239796 tert-butyl4-{(3,4-dimethoxyphenethyl)[2-(1H-indol-3-yl)acetyl]amino}-1-piperidine carboxylate; somatostatin receptors modulator; anticarcinogenic agent; acromegalia, hypophyseal adenomas, endocrine gastroenteropancreatic tumors including carcinoid syndrome; reducing amination of N-substituted piperidone
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005CA2562554A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005CA2561555A1 Bicyclic aromatic sulfinyl derivatives
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1587792A1 Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
10/26/2005EP1587791A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/26/2005EP1587790A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/26/2005EP1587789A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/26/2005EP1587518A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005EP0950050B1 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 380